OUR PRODUCTS

MOBILE APPS

GENERAL INFO

GYRE

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Gyre Therapeutics (GYRE) Earnings Date & Reports

Gyre Therapeutics Inc is a commercial-stage pharmaceutical company developing and commercializing small-molecule anti-inflammatory and anti-fibrotic drugs targeting organ diseases, focusing specifically on organ fibrosis... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

GYRE is expected to report earnings to fall 101.90% to 1 cents per share on August 19

Gyre Therapeutics GYRE Stock Earnings Reports

Q2'25

Est.

$0.02

Q2'23

Missed

by $0.98

Q1'23

Beat

by $0.22

Q4'22

Missed

by $18.94

Q3'22

Missed

by $2.30

The last earnings report on August 03 showed earnings per share of -104 cents, missing the estimate of -7 cents. With 22.15K shares outstanding, the current market capitalization sits at 651.82M.

View a ticker or compare two or three

Compare

GYRE

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For GYRE
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GYRE showed earnings on August 03, 2023. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

12770 High Bluff Drive

Phone

+1 619 949-3681

Employees

Web

https://www.gyretx.com